In late Oct. 2022, Emory University appointed Ravi I Thadhani, MD, MPH, to Executive Vice President for Health Affairs (EVPHA). He will also serve as the executive director of Emory’s Woodruff Health Sciences Center and vice chair of the Emory Healthcare Board of Directures. On Jan. 1, 2023, Thadhani will begin his tenure at Emory.
Thadhani currently serves as chief academic officer and dean for faculty affairs for Mass General Brigham and professor of medicine at Harvard Medical School, both in Boston, Massachusetts. At Mass General Brigham, he is a member of the executive leadership team and oversees graduate medical education, professional development and a $2.3 billion research enterprise.
With more than 30 years as a general and specialized internal medicine physician, Thadhani has extensive experience in patient care, research and clinical trials. He has led a successful research lab with continuous federal funding for more than 25 years, with a focus on kidney disease and developing diagnostics and therapeutics for patients with preeclampsia.
Thadhani has performed several clinical trials focused on effective treatments and preventative measures for preeclampsia, which is one of the leading causes of maternal and perinatal morbidity and mortality.
He is the author or co-author of more than 300 scientific manuscripts and has published in top-tier journals including the New England Journal of Medicine, Lancet and Journal of the American Medical Association.
As EVPHA, Thadhani will oversee Emory’s academic health sciences center, the Woodruff Health Sciences Center (WHSC), and in this position will help shape the next era of research, training and health-care delivery innovation. He will also provide oversight of Emory Healthcare’s CEO and leadership team.
